Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

RESMETIROM vs REVOLADE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

RESMETIROM vs REVOLADE: Safety Overview

Metric RESMETIROM REVOLADE
Total FAERS Reports 881 101
Deaths Reported 26 24
Death Rate 3.0% 23.8%
Hospitalizations 50 43
Average Patient Age 58.1 yrs 64.1 yrs
% Female Patients 65.3% N/A
FDA Approval Date Mar 14, 2024 N/A
Manufacturer Madrigal Pharmaceuticals, Inc. N/A
Route ORAL N/A
Marketing Status Prescription N/A